Lv2
200 积分 2024-04-25 加入
Patients’ knowledge and experience of adjuvant endocrine therapy for early breast cancer: A European study
2天前
已完结
Long‐term safety and efficacy of sustained eculizumab treatment in patients with paroxysmal nocturnal haemoglobinuria
14天前
已完结
Real-World Treatment Patterns, Healthcare Resource Utilization, Costs, and Survival Among Medicare Beneficiaries with Diffuse Large B-Cell Lymphoma (DLBCL)
21天前
已关闭
Global patterns and trends in breast cancer incidence and mortality across 185 countries
1个月前
已完结
Real-world (RW) risk of recurrence among patients (pts) diagnosed with stage II-III HR+/HER2− early breast cancer (EBC) treated with endocrine therapy (ET) in the US
2个月前
已完结
Significantly worse survival of patients with NIH-defined chronic graft-versus-host disease and thrombocytopenia or progressive onset type: results of a prospective study
4个月前
已完结
The Importance of Treatment Response for Outcome of Patients With Chronic Graft-Versus-Host Disease
4个月前
已完结
Treatment-Sensitive and Treatment-Dependent Chronic Graft-versus-Host Disease Yield Superior Failure-Free and Overall Survival Compared to Treatment-Resistant Chronic Graft-versus-Host Disease
4个月前
已完结
Impact of cytopenias and early versus late treatment with ruxolitinib in patients with steroid-refractory acute or chronic graft-versus-host disease
4个月前
已完结
Endocrine therapy or chemotherapy as first-line therapy in hormone receptor–positive HER2-negative metastatic breast cancer patients
4个月前
已完结
皖公网安备34019202002308
